Understanding and addressing somatic symptoms are complex in older adults, who have more comorbid medical illnesses. This article describes a systematic review of the literature on somatic symptoms in older patients with anxiety disorders. Additionally, the hypothesis was tested that somatic symptoms would respond to selective serotonin reuptake inhibitor treatment in 30 anxious patients aged 60 years and older who participated in a 32-week trial of citalopram. The literature review showed few original data articles about somatic symptoms in older patients with anxiety disorders. These articles suggest that such a relationship is common and that treatment of anxiety, or anxious depression, is associated with a reduction in somatic symptoms. In the analysis, citalopram treatment was associated with a significant decrease in several somatic symptoms from pretreatment baseline. It is concluded that somatic symptoms in older adults with anxiety disorders or anxious depression often improve with successful antidepressant treatment. However, additional treatment and integrated approaches are likely to be necessary for many such individuals.
Uhlenhuth EH, Balter MB, Mellinger GD, Cisin IH, Clinthorne J. Symptom checklist syndromes in the general population. Correlations with psychotherapeutic drug use. Arch Gen Psychiatry. 1983;40:1167-1173.
2.
Lindesay J, Briggs K, Murphy E.The Guy’s/Age Concern survey. Prevalence rates of cognitive impairment, depression and anxiety in an urban elderly community. Br J Psychiatry. 1989;155:317-329.
3.
Manela M, Katona C, Livingston G.How common are the anxiety disorders in old age?Int J Geriatr Psychiatry. 1996;11:65-70.
4.
Beekman AT, Bremmer MA, Deeg DJ, et al.Anxiety disorders in later life: a report from the Longitudinal Aging Study Amsterdam. Int J Geriatr Psychiatry. 1998;13:717-726.
5.
Mulsant BH, Reynolds CF, Shear MK, Sweet RA, Miller MD. Comorbid anxiety disorders in late-life depression. Anxiety. 1996;2:242-247.
6.
Lenze EJ, Mulsant BH, Shear MK, et al.Anxiety disorders in depressed elderly patients. Am J Psychiatry. 2000;15:722-728.
7.
Alonso J, Angermeyer MC, Bernert S, et al.12-Month comorbidity patterns and associated factors in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl. 2004;420:28-37.
8.
Chambers JA, Power KG, Durham RC. The relationship between trait vulnerability and anxiety and depressive diagnoses at long-term follow-up of Generalized Anxiety Disorder. J Anxiety Disord. 2004;18:597-607.
9.
Crum RM, Storr CL, Chan YF, et al.Sleep disturbance and risk for alcohol-related problems. Am J Psychiatry. 2004;161:1197-1203.
10.
Pesa J, Lage MJ. The medical costs of migraine and comorbid anxiety and depression. Headache. 2004;33:562-570.
11.
Poikolainen, K.Risk factors for alcohol dependence: a case-control study. Alcohol Alcohol. 2000;35:190-196.
12.
Szanto K, Prigerson H, Houch P, et al.Suicidal ideation in elderly bereaved: the role of complicated grief. Suicide Life Threat Behav. 1997;27:194-207.
13.
Shapiro S, Skinner EA, Kessler LG, et al.Utilization of health and mental health services. Three Epidemiologic Catchment Area sites. Arch Gen Psychiatry. 1984;41:971-978.
14.
de Beurs E, van Balkom AJ, Van Dyck R, et al.Long-term outcome of pharmacological and psychological treatment for panic disorder with agoraphobia: a 2-year naturalistic follow-up. Acta Psychiatr Scand. 1999;99:59-67.
15.
Golden AG, Preston RA, Barnett SD, et al.Inappropriate medication prescribing in homebound older adults. J Am Geriatr Soc. 1999;47:948-953.
16.
Wijeratne C, Brodaty H, Hickie I.The neglect of somatoform disorders by old age psychiatry: some explanations and suggestions for future research. Int J Geriatr Psychiatry. 2003;18:812-819.
17.
Sheehan B, Banerjee S.Review: somatization in the elderly. Int J Geriatr Psychiatry. 1999;14:1044-1049.
18.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Association Press; 1994.
19.
Young EA, Abelson JL, Cameron OG. Effect of comorbid anxiety disorders on the hypothalamic-pituitary-adrenal axis response to a social stressor in major depression. Biol Psychiatry. 2004;56:113-120.
20.
Stordal E, Bjelland I, Dahl AA, Mykletun A.Anxiety and depression in individuals with somatic health problems. The Nord-Trondelag Health Study (HUNT). Scand J Prim Health Care. 2003;21:136-141.
21.
Haug TT, Mykletun A, Dahl AA. Are anxiety and depression related to gastrointestinal symptoms in the general population?Scand J Gastroenterol. 2002;37:294-298.
22.
Eckhardt-Henn A, Breuer P, Thomalske C, Hoffmann SO, Hopf HC. Anxiety disorders and other psychiatric subgroups in patients complaining of dizziness. J Anxiety Disord. 2003;17:369-388.
23.
Zwart JA, Dyb G, Hagen K, et al.Depression and anxiety disorders associated with headache frequency. The Nord-Trondelag Health Study. Eur J Neurol. 2003;10:147-152.
24.
Wetherell JL, Thorp SR, Patterson TL, Golshan S, Jeste DV, Gatz M.Quality of life in geriatric generalized anxiety disorder: a preliminary investigation. J Psychiatr Res. 2004;38:305-312.
25.
Casten RJ, Parmelee PA, Kleban MH, Lawton MP, Katz IR. The relationships among anxiety, depression, and pain in a geriatric institutionalized sample. Pain. 1995;61:271-276.
26.
Creamer P, Lethbridge-Cejku M, Costa P, Tobin JD, Herbst JH, Hochberg MC. The relationship of anxiety and depression with self-reported knee pain in the community: data from the Baltimore Longitudinal Study of Aging. Arthritis Care Res. 1999;12:3-7.
27.
Brouwer B, Musselman K, Culham E.Physical function and health status among seniors with and without a fear of falling. Gerontology. 2004;50:135-141.
28.
Fletcher PC, Hirdes JP. Restriction in activity associated with fear of falling among community-based seniors using home care services. Age Ageing. 2004;33:273-279.
29.
Naik AD, Concato J, Gill TM. Bathing disability in community-living older persons: common, consequential, and complex. J Am Geriatr Soc. 2004;52:1805-1810.
30.
Schappert SM. National Ambulatory Medical Care Survey: 1989 summary. Vital Health Stat. 1992; 13(110):1-80.
31.
Kroenke K, Jackson JL, Chamberlin J.Depressive and anxiety disorders in patients presenting with physical complaints: clinical predictors and outcome. Am J Med. 1997;103:339-347.
32.
Jackson JL, Houston JS, Hanling SR, Terhaar KA, Yun JS. Clinical predictors of mental disorders among medical outpatients. Arch Intern Med. 2001;161:875-879.
33.
Borkovec TD, Robison E, Pruzinsky T, DePree JA. Preliminary exploration of worry: some characteristics and processes. Behav Res Ther. 1983;21: 9-16.
34.
Keefe F, Brown G, Wallston KA, Caldwell DS. Coping with rheumatoid arthritis: catastrophizing as a maladaptive strategy. Pain. 1989;37:51-56.
35.
Turner JA, Jensen MP, Romano JM. Do beliefs, coping, and catastrophizing independently predict functioning in patients with chronic pain?Pain. 200;85:115-125.
36.
Wetherell JL, Kaplan RM, Kallenberg G, Dresselhaus TR, Sieber WJ, Lang AJ. Mental health treatment preferences of older and younger primary care patients. Int J Psychiatry Med. 2004;34:219-233.
37.
Harman JS, Rollman BL, Hanusa BH, Lenze EJ, Shear MK. Physician office visits of adults for anxiety disorders in the United States: 1985-1998. J Gen Intern Med. 2002;17:165-172.
38.
Lenze EJ, Pollock BG, Shear MK, Mulsant BH, Bharucha A, Reynolds CF. Treatment considerations for anxiety in the elderly. CNS Spectr. 2003;8:6-13.
39.
Wetherell JL, Gatz M, Craske MG:Treatment of generalized anxiety disorder in older adults. J Consult Clin Psychol. 2003;71:31-40.
40.
Katz IR, Reynolds CF, Alexopoulos GS, Hackett D. Venlafaxine ER as a treatment for generalized anxiety disorder in older adults: pooled analysis of five randomized placebo-controlled clinical trials. J Am Geriatr Soc. 2002;50:18-24.
41.
Lenze EJ, Mulsant BH, Dew MA, et al: Good treatment outcomes in late-life depression with comorbid anxiety. J Affect Disord. 2003;77:247-254.
42.
Mulsant BH, Pollock BG, Nebes R, et al.A twelve-week, double-blind, randomized comparison of nortriptyline and paroxetine in older depressed inpatients and outpatients. Am J Geriatr Psychiatry. 2001;9:406-414.
43.
Lenze EJ, Blank S, Houck P, Mulsant BH, Shear MK, Reynolds CF. Treatment of anxiety disorders in elderly: a 32-week trial of citalopram. Paper presented at: Annual Meeting of the Anxiety Disorders Association of America; 2005; Seattle, Wash.
44.
Hamilton M.The assessment of anxiety states by rating. Br J Med Psychol. 1959;32:50-55.
45.
Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K.The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand Suppl. 1987;334:1-100.
46.
Fava M.The role of the serotonergic and noradrenergic neuro-transmitter systems in the treatment of psychological and physical symptoms of depression. J Clin Psychiatry. 2003;64:26-29.
47.
Fava M, Mallinckrodt CH, Detke MJ, Watkin JG, Wohlreich MM. The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates?J Clin Psychiatry. 2004;65:521-530.
48.
Dunner DL, Goldstein DJ, Mallinckrodt C, Lu Y, Detke MJ. Duloxetine in treatment of anxiety symptoms associated with depression. Depress Anxiety. 2003;18:53-61.
49.
Schatzberg AF, Kremer C, Rodrigues HE, Murphy GM Jr.Mirtazapine vs. Paroxetine Study Group. Double-blind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients. Am J Geriatr Psychiatry. 2002;10:541-550.
50.
Taylor K, Rowbotham MC. Venlafaxine hydrochloride and chronic pain. West J Med. 1996;165:147-148.
51.
Yilmaz ME, Kadiroglu AK, Kara IH, Dikici S.Venlafaxine in the treatment of painful peripheral diabetic neuropathy in a uremic patient undergoing hemodialysis. Med Gen Med. 2002;4:23.
52.
Oslin DW, Ten Have TR, Streim JE, et al.Probing the safety of medications in the frail elderly: evidence from a randomized clinical trial of sertraline and venlafaxine in depressed nursing home residents. J Clin Psychiatry. 2003;64:875-882.
53.
Harrison CL, Ferrier N, Young AH. Tolerability of high-dose venlafaxine in depressed patients. J Psychopharmacol. 2004;18:200-204.
54.
Wagner AK, Zhang F, Soumerai SB, et al.Benzodiazepine use and hip fractures in the elderly: who is at greatest risk?Arch Intern Med. 2004;164:1567-1572.
55.
Stanley MA, Diefenbach GJ, Hopko DR. Cognitive behavioral treatment for older adults with generalized anxiety disorder: a therapist manual for primary care settings. Behav Modif. 2004;28:73-117.
56.
Wetherell JL, Sorrell JT, Thorp SR, Patterson TL. Psychological interventions for late-life anxiety: a review and early lessons from the CALM study. J Geriatr Psychiatry Neurol. 2005;18: 72-82.
57.
Orsillo SM, Roemer L, Barlow DH. Integrating acceptance and mindfulness into existing cognitive-behavioral treatment for GAD: a case study. Cognit Behav Pract. 2003;10:222-230.
58.
Kroenke K.Patients presenting with somatic complaints: epidemiology, psychiatric comorbidity and management. Int J Methods Psychiatr Res. 2003;12:34-43.
59.
Mulsant BH, Pollock BG, Kirshner M, Shen C, Dodge H, Ganguli M.Serum anticholinergic activity in a community-based sample of older adults: relationship with cognitive performance. Arch Gen Psychiatry. 200;60:198-203.
